Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.96 USD | +2.23% | -0.36% | +16.62% |
05-28 | Morgan Stanley Raises Price Target on Colgate-Palmolive to $103 From $101 | MT |
05-16 | Colgate Palmolive Insider Sold Shares Worth $2,094,940, According to a Recent SEC Filing | MT |
Sales 2024 * | 20.22B 27.54B | Sales 2025 * | 21.05B 28.67B | Capitalization | 76.27B 104B |
---|---|---|---|---|---|
Net income 2024 * | 2.89B 3.93B | Net income 2025 * | 3.14B 4.27B | EV / Sales 2024 * | 4.14 x |
Net Debt 2024 * | 7.35B 10.01B | Net Debt 2025 * | 6.89B 9.39B | EV / Sales 2025 * | 3.95 x |
P/E ratio 2024 * |
26.5
x | P/E ratio 2025 * |
24.1
x | Employees | 34,000 |
Yield 2024 * |
2.14% | Yield 2025 * |
2.24% | Free-Float | 55.92% |
Latest transcript on Colgate-Palmolive Company
1 day | +2.23% | ||
1 week | -0.36% | ||
1 month | +0.05% | ||
3 months | +7.48% | ||
6 months | +18.12% | ||
Current year | +16.62% |
Managers | Title | Age | Since |
---|---|---|---|
Noel Wallace
CEO | Chief Executive Officer | 59 | 86-12-31 |
Stanley Sutula
DFI | Director of Finance/CFO | 58 | 20-11-08 |
Stephan Habif
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
C. Harris
BRD | Director/Board Member | 67 | 16-03-13 |
John Bilbrey
BRD | Director/Board Member | 67 | 15-03-10 |
John Cahill
BRD | Director/Board Member | 66 | 05-10-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.54% | 562 M€ | -0.36% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 92.96 | +2.23% | 6,647,992 |
24-05-30 | 90.93 | -0.39% | 3,148,024 |
24-05-29 | 91.29 | -0.71% | 3,114,962 |
24-05-28 | 91.94 | -1.46% | 4,276,926 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.62% | 76.27B | |
+12.28% | 388B | |
+12.61% | 136B | |
-12.57% | 65.56B | |
-15.65% | 44.23B | |
-10.36% | 36.96B | |
+6.37% | 35.04B | |
+7.80% | 18.02B | |
+12.30% | 15.57B | |
-2.17% | 11.58B |
- Stock Market
- Equities
- CL Stock